Methyltransferase SMYD2 Activates STAT3 to Drive Kidney Scarring After Cisplatin
Researchers report that the methyltransferase SMYD2 activates STAT3 to drive partial EMT and renal fibrosis in cisplatin-induced chronic kidney disease.
Tag: LLY507
POPULAR NEWS
-
Rhizobacteria Screen Points to a Two-Strain Biofertilizer Candidate for Sangyod Rice
-
New AI Network Monitors High-Speed Train Brake Pads Across Different Speeds
-
Neuropsychiatric Symptoms in Alzheimer’s Disease Linked to Amyloid and Heat Shock Proteins
-
Fetal day-night rhythms in the womb predict infant sleep patterns